Skip to main content
The BMJ logoLink to The BMJ
letter
. 1990 Mar 24;300(6727):814–816.

NSAIDs and peptic ulcers.

PMCID: PMC1662548  PMID: 2322751

Full text

PDF
814

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beardon P. H., Brown S. V., McDevitt D. G. Gastrointestinal events in patients prescribed non-steroidal anti-inflammatory drugs: a controlled study using record linkage in Tayside. Q J Med. 1989 Jun;71(266):497–505. [PubMed] [Google Scholar]
  2. Collins A. J., Davies J., Dixon A. S. A prospective endoscopic study of the effect of Orudis and Oruvail on the upper gastrointestinal tract, in patients with osteoarthritis. Br J Rheumatol. 1988 Apr;27(2):106–109. doi: 10.1093/rheumatology/27.2.106. [DOI] [PubMed] [Google Scholar]
  3. Ehsanullah R. S., Page M. C., Tildesley G., Wood J. R. Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine. BMJ. 1988 Oct 22;297(6655):1017–1021. doi: 10.1136/bmj.297.6655.1017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Graham D. Y., Agrawal N. M., Roth S. H. Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial. Lancet. 1988 Dec 3;2(8623):1277–1280. doi: 10.1016/s0140-6736(88)92892-9. [DOI] [PubMed] [Google Scholar]
  5. Hawkey C. J. Non-steroidal anti-inflammatory drugs and peptic ulcers. BMJ. 1990 Feb 3;300(6720):278–284. doi: 10.1136/bmj.300.6720.278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Lanza F. L., Aspinall R. L., Swabb E. A., Davis R. E., Rack M. F., Rubin A. Double-blind, placebo-controlled endoscopic comparison of the mucosal protective effects of misoprostol versus cimetidine on tolmetin-induced mucosal injury to the stomach and duodenum. Gastroenterology. 1988 Aug;95(2):289–294. doi: 10.1016/0016-5085(88)90482-9. [DOI] [PubMed] [Google Scholar]
  7. Lanza F. L., Fakouhi D., Rubin A., Davis R. E., Rack M. F., Nissen C., Geis S. A double-blind placebo-controlled comparison of the efficacy and safety of 50, 100, and 200 micrograms of misoprostol QID in the prevention of ibuprofen-induced gastric and duodenal mucosal lesions and symptoms. Am J Gastroenterol. 1989 Jun;84(6):633–636. [PubMed] [Google Scholar]
  8. Robinson M. G., Griffin J. W., Jr, Bowers J., Kogan F. J., Kogut D. G., Lanza F. L., Warner C. W. Effect of ranitidine on gastroduodenal mucosal damage induced by nonsteroidal antiinflammatory drugs. Dig Dis Sci. 1989 Mar;34(3):424–428. doi: 10.1007/BF01536266. [DOI] [PubMed] [Google Scholar]
  9. Somerville K., Faulkner G., Langman M. Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet. 1986 Mar 1;1(8479):462–464. doi: 10.1016/s0140-6736(86)92927-2. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES